Production (Stage)
Palisade Bio, Inc.
PALI
$0.6967
$0.01642.41%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | 33.31% | 4.10% | 14.53% | -15.68% | -18.71% |
Total Depreciation and Amortization | -- | -100.00% | 0.00% | 0.00% | -- |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -55.41% | 1,918.18% | -97.65% | 212.00% | -26.11% |
Change in Net Operating Assets | -127.40% | 116.67% | 205.36% | -42.86% | 790.91% |
Cash from Operations | 2.02% | 24.00% | 10.46% | -10.03% | -15.80% |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -- | -- | -- | -- | -- |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | 48.72% | -39.29% | -- | 100.00% | -56.44% |
Issuance of Common Stock | -- | -- | -100.00% | 60.25% | 14,623.53% |
Repurchase of Common Stock | -- | -- | 100.00% | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -48.33% | -76.47% | 83.41% | -27.73% | -542.00% |
Cash from Financing | -106.20% | 2,412.22% | -105.03% | 76.68% | 1,610.45% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -245.48% | 153.76% | -4,402.60% | 106.66% | 59.86% |